Today, pharmacovigilance is a top priority of every pharmaceutical company in the globally diverse and evolving regulatory environment. With the increasing number of adverse drug reactions and the accelerated demand for personalized medicines, the pharmacovigilance (PV) function is growing exponentially and becoming more complex. Existing PV strategies are falling short of meeting the requirements of this increasingly dynamic landscape. Pharmaceutical companies are rethinking their PV operating models, and setting up more diligent and effective processes and robust technologies to transform their pharmacovigilance function.
Wipro is a global leader in providing pharmacovigilance solutions through its widely accepted digital transformation and delivery footprint in the US, EMEA, AFME, LATAM, and APAC regions. Our scalable and sustainable PV operating model brings value to organizations by optimizing human capital, and by enhancing product quality and patient safety.